Lung Cancer Trial, Recruiting (NCT02978521)

Lung Cancer Trial, Recruiting NCT02978521 Sponsor: Instituto Nacional de Cancerologia de Mexico Condition: Lung Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT02978521 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lung Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with advanced non-small-cell lung cancer (a specific type of lung cancer).
People who are generally well enough to carry out daily activities with little or no limitation (confirm with trial site).
People who are expected to live for more than 12 weeks.
People whose doctor has determined them suitable for treatment with chemotherapy or targeted drug therapy for their lung cancer.
People who have had a recent heart tracing test (ECG) that showed no irregular heartbeat.

Who may not be able to join:

People who have cancer that has spread to the brain and is currently causing symptoms.
People whose pain is not well controlled, rating above 5 on a standard 10-point pain scale.
People who have high blood pressure that is not under control (readings above 140/100 mmHg).
People who already take part in regular moderate to intense physical exercise at least 3 days per week.
People who do not live in Mexico City or who are unable to attend in-person therapy sessions.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Oscar Arrieta, Head of Thoracic Oncology Unit

Phone: 01 55 56280400

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT02978521

Sponsor: Instituto Nacional de Cancerologia de Mexico

Phase: Not Applicable

Status: Recruiting

Condition: Lung Cancer

Trial contact: 01 55 56280400

More information: https://clinicaltrials.gov/study/NCT02978521

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with advanced non-small-cell lung cancer (a specific type of lung cancer).
People who are generally well enough to carry out daily activities with little or no limitation (confirm with trial site).
People who are expected to live for more than 12 weeks.
People whose doctor has determined them suitable for treatment with chemotherapy or targeted drug therapy for their lung cancer.
People who have had a recent heart tracing test (ECG) that showed no irregular heartbeat.

Who may not be able to join:

People who have cancer that has spread to the brain and is currently causing symptoms.
People whose pain is not well controlled, rating above 5 on a standard 10-point pain scale.
People who have high blood pressure that is not under control (readings above 140/100 mmHg).
People who already take part in regular moderate to intense physical exercise at least 3 days per week.
People who do not live in Mexico City or who are unable to attend in-person therapy sessions.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Instituto Nacional de Cancerologia de Mexico

Registry

ClinicalTrials.gov

Start date

5 August 2016

Est. completion

5 December 2026

Where this trial is recruiting

🇲🇽 Mexico

Primary endpoints

Pulmonary function

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov